These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30593144)

  • 1. Etiologic impact on difference on clinical outcomes of patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.
    Chen JS; Niu XW; Chen FM; Yao YL
    Medicine (Baltimore); 2018 Dec; 97(52):e13725. PubMed ID: 30593144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.
    Chen Y; Duan C; Liu F; Shen S; Chen P; Bin J
    PLoS One; 2014; 9(4):e94614. PubMed ID: 24732141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular lead location and outcomes among patients with cardiac resynchronization therapy: A meta-analysis.
    Ali-Ahmed F; Dalgaard F; Allen Lapointe NM; Kosinski AS; Blumer V; Morin DP; Sanders GD; Al-Khatib SM
    Prog Cardiovasc Dis; 2021; 66():53-60. PubMed ID: 33864874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.
    Adelstein EC; Tanaka H; Soman P; Miske G; Haberman SC; Saba SF; Gorcsan J
    Eur Heart J; 2011 Jan; 32(1):93-103. PubMed ID: 20971745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of gender difference on clinical and echocardiographic outcomes in patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.
    Yin FH; Fan CL; Guo YY; Zhu H; Wang ZL
    PLoS One; 2017; 12(4):e0176248. PubMed ID: 28453545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of image-guided techniques in cardiac resynchronization therapy: a meta-analysis.
    Hu X; Xu H; Hassea SRA; Qian Z; Wang Y; Zhang X; Hou X; Zou J
    BMC Cardiovasc Disord; 2021 May; 21(1):255. PubMed ID: 34024286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of aetiology on long-term effects of resynchronization on cardiac structure and function in patients treated with β-blockers.
    Zacà V; Baiocchi C; Gaddi R; Gentilini R; Lunghetti S; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):227-33. PubMed ID: 21252694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A multi-center study on the long-term mortality and related risk factors in patients with chronic heart failure receiving resynchronization therapy].
    Qi SY; Wang DM; Yu HB; Ding C; Tian FL; Ru LS; Li J; Zhang B; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):951-955. PubMed ID: 27903393
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy.
    Cimino S; Maestrini V; Cantisani D; Petronilli V; Filomena D; Gatto MC; Birtolo LI; Piro A; Lavalle C; Agati L
    Echocardiography; 2019 Aug; 36(8):1475-1481. PubMed ID: 31260156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional contributions to left ventricular stroke volume determined by cardiac magnetic resonance imaging in cardiac resynchronization therapy.
    Östenson B; Ostenfeld E; Werther-Evaldsson A; Roijer A; Bakos Z; Kanski M; Heiberg E; Arheden H; Borgquist R; Carlsson M
    BMC Cardiovasc Disord; 2021 Oct; 21(1):519. PubMed ID: 34702172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy.
    Kloosterman M; van Stipdonk AMW; Ter Horst I; Rienstra M; Van Gelder IC; Vos MA; Prinzen FW; Meine M; Vernooy K; Maass AH
    ESC Heart Fail; 2020 Apr; 7(2):645-653. PubMed ID: 31991067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy outcomes with left ventricular lead concordant with latest mechanical activation: A meta-analysis.
    Allen LaPointe NM; Ali-Ahmed F; Dalgaard F; Kosinski AS; Sanders Schmidler G; Al-Khatib SM
    Pacing Clin Electrophysiol; 2022 Aug; 45(8):930-939. PubMed ID: 35687711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.